1.
Epidemiological serosurvey of Hepatitis B in China—Declining HBV prevalence due to Hepatitis B vaccination
by Liang, Xiaofeng
Vaccine, 2009, Vol.27 (47), p.6550-6557

2.
Hepatitis A virus seroprevalence by age and world region, 1990 and 2005
by Jacobsen, Kathryn H
Vaccine, 2010, Vol.28 (41), p.6653-6657

3.
Missed clinical opportunities: Provider recommendations for HPV vaccination for 11–12 year old girls are limited
by Vadaparampil, Susan T
Vaccine, 2011, Vol.29 (47), p.8634-8641

4.
The economic burden of sixteen measles outbreaks on United States public health departments in 2011
by Ortega-Sanchez, Ismael R
Vaccine, 2013, Vol.32 (11), p.1311-1317

5.
The case test-negative design for studies of the effectiveness of influenza vaccine
by Foppa, Ivo M
Vaccine, 2013, Vol.31 (30), p.3104-3109

6.
Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
by Coleman, Christopher M
Vaccine, 2014, Vol.32 (26), p.3169-3174

7.
Impact of vaccinating boys and men against HPV in the United States
by Elbasha, Elamin H
Vaccine, 2010, Vol.28 (42), p.6858-6867

8.
Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England
by Mesher, D
Vaccine, 2013, Vol.32 (1), p.26-32

9.
Predictors of HPV vaccine uptake among women aged 19–26: Importance of a physician's recommendation
by Rosenthal, S.L
Vaccine, 2009, Vol.29 (5), p.890-895

10.
A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available
by Ishikawa, Tomohiro
Vaccine, 2014, Vol.32 (12), p.1326-1337

11.
Educational interventions to increase HPV vaccination acceptance: A systematic review
by Fu, Linda Y
Vaccine, 2014, Vol.32 (17), p.1901-1920

12.

13.
Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice
by Wen, Yingxia
Vaccine, 2014, Vol.32 (30), p.3796-3804

14.

15.
The cost-effectiveness of male HPV vaccination in the United States
by Chesson, Harrell W
Vaccine, 2011, Vol.29 (46), p.8443-8450

16.
Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia
by Buttery, J.P
Vaccine, 2011, Vol.29 (16), p.3061-3066

17.
Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom
by Lau, Wallis C.Y
Vaccine, 2015, Vol.33 (39), p.5072-5079

18.
“HPV? Never heard of it!”: A systematic review of girls’ and parents’ information needs, views and preferences about human papillomavirus vaccination
by Hendry, Maggie
Vaccine, 2013, Vol.31 (45), p.5152-5167

19.
Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice
by Kim, Eun
Vaccine, 2014, Vol.32 (45), p.5975-5982

20.
The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns
by Wijnans, Leonoor
Vaccine, 2012, Vol.31 (8), p.1246-1254
